Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online June 22, 2006
Stem Cells Vol. 24 No. 10 October 2006, pp. 2309 -2318
doi:10.1634/stemcells.2006-0010; www.StemCells.com
© 2006 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2006-0010v1
24/10/2309    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldstein, L. J.
Right arrow Articles by Velazquez, O. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldstein, L. J.
Right arrow Articles by Velazquez, O. C.

TRANSLATIONAL AND CLINICAL RESEARCH

Endothelial Progenitor Cell Release into Circulation Is Triggered by Hyperoxia-Induced Increases in Bone Marrow Nitric Oxide

Lee J. Goldsteina, Katherine A. Gallaghera, Stephen M. Bauera, Richard J. Bauera, Vijay Baireddya, Zhao-Jun Liua, Donald G. Buerkb, Stephen R. Thomc, Omaida C. Velazqueza

aDepartment of Surgery and
cDepartment of Emergency Medicine, Institute for Environmental Medicine, University of Pennsylvania Medical Center;
bDepartments of Physiology and Bioengineering, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Key Words. Endothelial progenitor cell • Hyperbaric oxygen • Hyperoxia • Nitric oxide • Neovascularization • Wound healing

Correspondence: Omaida C. Velazquez, M.D., Department of Surgery, University of Pennsylvania Medical Center, 4th Floor Silverstein Pavilion, 3400 Spruce Street, Philadelphia, Pennsylvania 19124, USA. Telephone: 215-662-6451; Fax: 215-662-4871; e-mail: omaida.velazquez{at}uphs.upenn.edu

Received January 5, 2006; accepted for publication June 15, 2006.
First published online in STEM CELLS EXPRESS   June 22, 2006.



Endothelial progenitor cells (EPC) are known to contribute to wound healing, but the physiologic triggers for their mobilization are often insufficient to induce complete wound healing in the presence of severe ischemia. EPC trafficking is known to be regulated by hypoxic gradients and induced by vascular endothelial growth factor-mediated increases in bone marrow nitric oxide (NO). Hyperbaric oxygen (HBO) enhances wound healing, although the mechanisms for its therapeutic effects are incompletely understood. It is known that HBO increases nitric oxide levels in perivascular tissues via stimulation of nitric oxide synthase (NOS). Here we show that HBO increases bone marrow NO in vivo thereby increasing release of EPC into circulation. These effects are inhibited by pretreatment with the NOS inhibitor L-nitroarginine methyl ester (L-NAME). HBO-mediated mobilization of EPC is associated with increased lower limb spontaneous circulatory recovery after femoral ligation and enhanced closure of ischemic wounds, and these effects on limb perfusion and wound healing are also inhibited by L-NAME pretreatment. These data show that EPC mobilization into circulation is triggered by hyperoxia through induction of bone marrow NO with resulting enhancement in ischemic limb perfusion and wound healing.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.stemcellsportal.com/
Copyright © 2006 by AlphaMed Press.